Latest Research, Industry, Medical and Scientific News
Christopher K. Payne, MD, FACS, to Receive Distinguished Philanthropist Award
Since 1989, the American College of Surgeons (ACS) has acknowledged individuals who have distinguished themselves through their exemplary investments in the mission of the College and in philanthropy with the Distinguished Philanthropist Award. The Board of Directors of the ACS Foundation will present the 2019 Distinguished Philanthropist Award to Christopher K. Payne, MD, FACS, at its annual Donor Recognition Luncheon Monday. The award recognizes Dr. Payne for his philanthropic endeavors, service to the surgical profession, and long-lasting contributions to the medical community and the ACS. Read more.
Source: American College of Surgeons Clinical Congress News, October 31, 2019
Catering to the Moderate to Heavy Incontinence Sufferer
While much of the new product development for adult incontinence today has led to thinner and thinner products for light incontinence, Illinois-based NorthShore Care Supply has focused on bringing innovation and dignity to those who suffer from moderate to heavy incontinence. Witnessing family members struggling to manage their incontinence supplies using traditional retail products is what led Adam Greenberg to start up an adult incontinence business while completing his MBA at the University of Chicago Booth School of Business in 2002. “At that that time, it was very confusing to shop for premium adult diapers online as everything sounded and looked the same and there was nobody that could help guide my family through this frustrating and embarrassing process,” says Greenberg, owner and president of NorthShore Care Supply. “So I studied up, and quickly became a diaper expert and was able to translate all the clinical specifications designed for nurses and hospitals into a very user friendly format that put families and patients at ease and made them feel like our products had a good chance to provide them the dignity and security that they’d been searching for.” Read more.
Source: Nonwovens Industry, October 17, 2019
Axonics Provides Full One-year Results From ARTISAN-SNM Pivotal Study
Axonics announced the presentation of detailed one-year results from its ARTISAN rechargeable sacral neuromodulation (r-SMN) pivotal study at a plenary session at the joint scientific meeting of the American Urogynecologic Society (AUGS) and the International Urogynecological Association (IUGA). The presentation of positive data, as well as numerous launch activities, highlighted Axonics’ first scientific meeting following the US Food and Drug Administration (FDA) clearance of the Axonics r-SNM System1 in September 2019. During the meeting, more than 350 physicians of the approximate 2,000 at the conference, attended a one-hour symposium at which experienced physician implanters from the ARTISAN-SNM pivotal study discussed their first-hand impressions of the Axonics r-SNM System and post-implant patient feedback. Read more.
Source: Neuro News, October 7, 2019
Medtronic Announces FDA Submission for InterStim™ Micro Neurostimulator and SureScan™ MRI Leads
Medtronic plc (MDT) today announced it has filed a pre-market approval (PMA) supplement with the United States Food and Drug Administration (FDA) for approval of its InterStim™ Micro neurostimulator and also its InterStim™ SureScan™ MRI leads. InterStim Micro is a rechargeable, implantable sacral neuromodulation (SNM) device to treat patients affected by overactive bladder, urinary urge incontinence, unobstructed urinary retention and fecal incontinence. The SureScan™ leads, which will be used in future implants of the recharge-free InterStim II system and rechargeable InterStim Micro system, are designed to provide full-body 1.5 and 3 Tesla MRI conditional labeling, pending FDA approval. Read more.
Source: Globe Newswire, October 7, 2019
Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable rechargeable sacral neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, today announced the approval of the Axonics r-SNM® System by the United States Food & Drug Administration (“FDA”). The Axonics System is the first rechargeable SNM system approved for sale in the United States, Europe, Canada and Australia. The FDA approval grants Axonics the right to market its product in the United States for the clinical indication of fecal incontinence. The approval includes the claim of a 15-year functional life and the ability of patients to undergo full-body MRI scans without the necessity of having the device explanted. Axonics has an additional pre-market approval (“PMA”) filing currently under review with the FDA for the clinical indications of overactive bladder (urinary urgency incontinence and urinary urgency frequency) as well as urinary retention for which the Company anticipates a determination in the near term. Read more.
Source: Business Wire, September 9, 2019
Survey: Seniors Choose to Endure Discomfort Instead of Asking Their Children for Assistance
Aeroflow Healthcare, an Inc. 5000 fastest growing company, announced the results of a proprietary survey designed to stress the importance of communication between seniors and their friends and family as they age. The third-party administered survey polled 1,003 adults aged 60 or older living in the United States and was completed over a span of three days in July 2019. To view the full survey results, please click here.
Notable survey results include:
64% of seniors would prefer assisted living to having their adult children care for them
46% of seniors are concerned they may become a burden on their family
54% of seniors would feel embarrassed discussing incontinence issues with friends or family
52% of seniors would try to hide incontinence or lie about it rather than ask for help
The survey results suggest that seniors are more worried about inconveniencing their adult children than receiving the care they need, and are willing to take considerable measures to avoid asking for help. Read more.
Source: PRNewswire, August 22, 2019